(1) Background: There are few data on anticoagulation therapy for left ventricular (LV) thrombosis following ST-segment elevation myocardial infarction (STEMI). The aim of this study was to assess whether microvascular obstruction (MVO) extent on cardiac magnetic resonance (CMR) worsened the prognosis of patients with LV thrombosis receiving anticoagulation. (2) Methods: reperfused STEMI patients undergoing CMR were enrolled. Patients were divided into 4 groups according to MVO and LV thrombosis presence or absence. Occurrence of major adverse cardiac events (MACE) was evaluated during follow-up. (3) Results: 80 STEMI patients were enrolled. According to MVO and LV thrombosis, 4 subgroups were obtained: patients with MVO and LV thrombosis (21 patients, 26%); patients with MVO without LV thrombosis (28 patients, 35%); patients without MVO with LV thrombosis (6 patients, 8%); patients without MVO and LV thrombosis (25 patients, 31%). All patients with LV thrombosis were treated with anticoagulation therapy. The median time to the follow-up was 11 months. Twenty-two patients (27%) experienced MACE. LV thrombosis treated with anticoagulation was an independent predictor of MACE (hazard ratio, 2.828; 95% confidence interval, 1.205–6.638; p = 0.017) and was associated with a worse prognosis (p = 0.012), regardless of MVO (p = 0.852), at Kaplan–Meier. (4) Conclusions: Patients with LV thrombosis treated with anticoagulation after a reperfused STEMI have a worse prognosis than those without; however, MVO extent did not worsen prognosis.
Background. Transaortic flow rate (FR) has been proposed as a flow-derived echocardiographic marker for risk stratification in severe aortic stenosis (AS). Its prognostic value in patients undergoing transcatheter aortic valve implantation (TAVI) and the influence of cardiac rhythm remain uncertain.Objectives. To assess the association between FR and all-cause mortality after TAVI and determine whether the association is modified by cardiac rhythm. Stroke volume index (SVi) was evaluated as a secondary parameter.Methods. We retrospectively studied 1,008 patients undergoing TAVI for severe AS. FR was analyzed per 50 mL/s increase and using a threshold of 210 mL/s. SVi was analyzed per 10 mL/m² increase and using a threshold of 35 mL/m². Associations with all-cause mortality were evaluated using Cox regression, including interaction terms between cardiac rhythm and FR or SVi in multivariable models.Results. Of 1,008 patients, 837 (83%) were in sinus rhythm (SR) and 171 (17%) had atrial fibrillation (AF). During a median follow-up of 29.7 months, higher FR was associated with lower mortality in SR (HR 0.853, 95% CI 0.745-0.977; p=0.021) but not in AF (HR 1.052, 95% CI 0.830-1.334; p=0.674). Similar findings were observed for SVi. No significant interaction was found between cardiac rhythm and FR (p=0.254) or SVi (p=0.415).Conclusions. Higher FR was associated with improved survival in SR but not in AF after TAVI. Cardiac rhythm did not modify the association between FR and mortality. Flow-derived parameters may be influenced by rhythm-related hemodynamic variability. Larger studies are needed to clarify their role in AF.